MA46453A - Composés imidazopyridazine utiles en tant que modulateurs de réponses il-12, il-23 et/ou ifn alpha - Google Patents

Composés imidazopyridazine utiles en tant que modulateurs de réponses il-12, il-23 et/ou ifn alpha

Info

Publication number
MA46453A
MA46453A MA046453A MA46453A MA46453A MA 46453 A MA46453 A MA 46453A MA 046453 A MA046453 A MA 046453A MA 46453 A MA46453 A MA 46453A MA 46453 A MA46453 A MA 46453A
Authority
MA
Morocco
Prior art keywords
compounds useful
ifn alpha
response modulators
alpha response
imidazopyridazine compounds
Prior art date
Application number
MA046453A
Other languages
English (en)
Inventor
Michael E Mertzman
Steven H Spergel
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MA46453A publication Critical patent/MA46453A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA046453A 2016-10-07 2017-10-02 Composés imidazopyridazine utiles en tant que modulateurs de réponses il-12, il-23 et/ou ifn alpha MA46453A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662405309P 2016-10-07 2016-10-07

Publications (1)

Publication Number Publication Date
MA46453A true MA46453A (fr) 2019-08-14

Family

ID=60117794

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046453A MA46453A (fr) 2016-10-07 2017-10-02 Composés imidazopyridazine utiles en tant que modulateurs de réponses il-12, il-23 et/ou ifn alpha

Country Status (8)

Country Link
US (1) US10836770B2 (fr)
EP (1) EP3523305B1 (fr)
JP (1) JP7097875B2 (fr)
KR (1) KR102531036B1 (fr)
CN (1) CN110036015B (fr)
ES (1) ES2902995T3 (fr)
MA (1) MA46453A (fr)
WO (1) WO2018067432A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6557436B1 (ja) 2018-03-12 2019-08-07 アッヴィ・インコーポレイテッド チロシンキナーゼ2媒介性シグナル伝達の阻害剤
JP7179161B2 (ja) 2018-09-10 2022-11-28 イーライ リリー アンド カンパニー 乾癬および全身性エリテマトーデスの処置に有用なピラゾロ[1,5-a]ピリミジン-3-カルボキサミド誘導体
EP3849969B1 (fr) * 2018-09-13 2023-04-19 Bristol-Myers Squibb Company Indazole carboxamides en tant qu'inhibiteurs de kinase
MX2021004538A (es) 2018-10-22 2021-09-10 Esker Therapeutics Inc Inhibidores de tyk2 y sus usos.
WO2020094363A1 (fr) 2018-11-05 2020-05-14 Syngenta Participations Ag Composés azole-amide à action pesticide
TWI800696B (zh) 2018-12-10 2023-05-01 美商美國禮來大藥廠 7-(甲基胺基)吡唑并[1,5-a]嘧啶-3-甲醯胺衍生物
EP3914357A4 (fr) * 2019-01-23 2022-10-12 Nimbus Lakshmi, Inc. Inhibiteurs de tyk2 et leurs utilisations
JP2022523434A (ja) 2019-03-08 2022-04-22 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 殺有害生物的に活性なアゾール-アミド化合物
US20220306599A1 (en) 2019-03-20 2022-09-29 Syngenta Crop Protection Ag Pesticidally active azole amide compounds
CN113597426A (zh) 2019-03-22 2021-11-02 先正达农作物保护股份公司 N-[1-(5-溴-2-嘧啶-2-基-1,2,4-三唑-3-基)乙基]-2-环丙基-6-(三氟甲基)吡啶-4-甲酰胺衍生物及相关的化合物作为杀昆虫剂
EP3962475A1 (fr) 2019-04-30 2022-03-09 Celgene Corporation Polythérapies comprenant de l'aprémilast et des inhibiteurs de tyk2
TWI810520B (zh) 2020-02-12 2023-08-01 美商美國禮來大藥廠 7-(甲基胺基)吡唑并[1,5-a]嘧啶-3-甲醯胺化合物
EP3944859A1 (fr) 2020-07-30 2022-02-02 Assistance Publique Hôpitaux de Paris Procédé de traitement des toxicités immunitaires induites par des inhibiteurs des points de contrôle immunitaire
WO2022037694A1 (fr) * 2020-08-20 2022-02-24 轶诺(浙江)药业有限公司 Classe de composés hétérocycliques à cinq et six chaînons et leur utilisation en tant qu'inhibiteurs de protéine kinase du récepteur
AU2021345181A1 (en) * 2020-09-16 2023-05-04 Alumis Inc Tyk2 inhibitors and uses thereof
CA3236262A1 (fr) 2021-10-25 2023-05-04 Isaac Marx Agents de degradation de tyk2 et leurs utilisations
CN116655636A (zh) * 2022-02-17 2023-08-29 上海轶诺药业有限公司 一类五元并六元杂环化合物及其作为蛋白激酶抑制剂的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176214B2 (en) 2003-05-21 2007-02-13 Bristol-Myers Squibb Company Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
WO2009100375A1 (fr) 2008-02-06 2009-08-13 Bristol-Myers Squibb Company Imidazopyridazines substituées utiles en tant qu’inhibiteurs de kinase
KR20140077963A (ko) * 2011-10-20 2014-06-24 글락소스미스클라인 엘엘씨 시르투인 조절제로서의 치환된 비시클릭 아자-헤테로사이클 및 유사체
ES2702126T3 (es) * 2013-12-10 2019-02-27 Bristol Myers Squibb Co Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa
JP6843135B2 (ja) * 2015-11-18 2021-03-17 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company IL−12、IL−23および/またはIFNα応答のモジュレーターとして有用なイミダゾピリダジン化合物

Also Published As

Publication number Publication date
KR20190057132A (ko) 2019-05-27
CN110036015B (zh) 2022-07-19
JP2019530699A (ja) 2019-10-24
JP7097875B2 (ja) 2022-07-08
EP3523305A1 (fr) 2019-08-14
US20190225620A1 (en) 2019-07-25
KR102531036B1 (ko) 2023-05-09
US10836770B2 (en) 2020-11-17
WO2018067432A1 (fr) 2018-04-12
ES2902995T3 (es) 2022-03-30
CN110036015A (zh) 2019-07-19
EP3523305B1 (fr) 2021-12-08

Similar Documents

Publication Publication Date Title
MA46453A (fr) Composés imidazopyridazine utiles en tant que modulateurs de réponses il-12, il-23 et/ou ifn alpha
DK3784661T3 (da) Hidtil ukendte heteroaryl-triazol- og heteroaryl-tetrazol-forbindelser som pesticider
BR112017008666A2 (pt) anticorpos anti-fgfr2/3 e métodos de uso dos mesmos
MA46620A (fr) Composés hétérobicycliques utiles en tant que modulateurs de réponses à il-12, il-23 et/ou ifn alpha
BR112017025828A2 (pt) dispositivo de nó hospedeiro e métodos de uso com o mesmo.
BR112017005381A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
BR112017005504A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
MA54386A (fr) Modulateurs de trex1
MA44772A (fr) 6-aminopyridine-3-yl thiazoles utilisés en tant que modulateurs de ror t
MA43705A (fr) Formulation pharmaceutique
BR112017011685A2 (pt) composições compreendendo 15-hepe e métodos de tratamento ou prevenção da fibrose usando as mesmas
BR112016026470A2 (pt) Composto modulador de hsp70, composição farmacêutica que o compreende e uso do referido composto
BR112017020230A2 (pt) composições de recursos preferenciais por térmitas e métodos
MA46760A (fr) Modulateurs de ror gamma
FR3037983B1 (fr) Huisserie neuve ou de renovation
ITUA20163470A1 (it) Formulazione antiappannante
DK3630092T3 (da) Formulering på basis af vitamin E eller en ester deraf til behandling af bakterie- og svampebiofilm
BR112018007981A2 (pt) composição para as unhas, métodos para fazer ou proteger as unhas e para preparar a composição, sistema de cuidado das unhas, kit de sistema de cuidado das unhas e sistema para as unhas
BR112017022814A2 (pt) dispositivo de acionamento de motor e refrigerador que emprega o mesmo.
ES1136731Y (es) Lapida laminada por colores
DK3691489T3 (da) Sko, i særdeleshed sikkerhedssko
DK3412339T3 (da) Indretning til fototerapi eller Grovers sygdom
ITUA20162062A1 (it) Dispositivo di azionamento di frenata e/o azionamento di frizione
TH182886B (th) ผลิตภัณฑ์เครื่องสำอางที่ประกอบด้วยส่วนผสมเครื่องสำอางที่เคลือบฝังไว้บนฟองน้ำ-ที่ไม่ละลายน้ำ ที่มีความสามารถในการป้องกันรังสีอัลตร้าไวโอเลต
FI20165358A (fi) Optinen sensori, järjestelmä ja menetelmät